PARP1 and breast cancer: By combing genetic screens with multi-omics analysis of matched PARP-sensitive and -resistance BRCA2-mutated mouse mammary tumors, PAR glycohydrolase (PARG) was found, the loss of which resulted in restoring PARylation formation and PARPi resistance [120].